Latest Insights on ESPO
Quick Takes: This Tells Me “Stay Bullish!” December 2, 2021 Bank It or Tank It, Quick Takes, Stocks, True Options Masters Chad is ignoring the headlines and sticking to what he knows: chart patterns. In today's Quick Takes, he's looking at TSLA, AMZN, FB, & more.
On DoorDashers, On Box’ers, On Chipmakers … C’mon, Becto! December 1, 2021 Great Stuff A Little Dash’ll Do Ya? It’s been, what … less than a week since COVID-19 Omicron debuted, and I’m already tired of it. And I’m sure you’re tired of hearing about Omicron as well, Great Ones. Wall Street is also tired of it, apparently, as stocks attempted to push sharply higher today. But, as resilient […]
How to Beat the Inflation Tapeworm December 1, 2021 Investment Opportunities, Real Talk, Stocks, U.S. Economy (4-minute read) Soaring demand and worker shortages are making the supply chain crisis worse. It’s the perfect storm for higher prices. But here’s how you can combat inflation today…
December’s Market Outlook: Buy the Omicron Dip! December 1, 2021 Monthly Market Outlook, Trading Strategies, True Options Masters In the last Monthly Market Outlook of the year, your True Options Masters share actionable trade ideas to buy the omicron dip!
A Stock-Picking Mutation to Beat the Omicron Threat November 30, 2021 Big Picture. Big Profits., Global Economy, News This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.





